Company CVAbout Akums Drugs & Pharmaceuticals Ltd 
Akums Drugs & Pharmaceuticals Ltd
Mid Cap
Pharmaceuticals & Drugs
Akums Drugs and Pharmaceuticals Limited was incorporated vide Certificate of Incorporation dated April 19, 2004 and received a Certificate for Commencement of Business dated May 13, 2004 issued by the RoC. Alkums Drugs & Pharmas are a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 31.48 Cr
Number of Shares
15.74 Cr
Face Value
INR 2.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
02-Aug-2024
15.74
31.48
10037708
2
Public Issue
31-May-2024
14.74
29.47
4291930
2
Further Issue
17-Mar-2023
14.31
28.61
71532175
2
Bonus Issue
24-Dec-2021
65.03
1.30
5202340
2
Stock Split
24-Dec-2021
7.15
14.31
65029250
2
Bonus Issue
13-Nov-2019
13.01
1.30
125585
10
Private Placement
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 16 Schemes (5.54%)
FIIs
Held by 33 FIIs (6.36%)
Promoter with highest holding
Akums Master Trust (sanjeev Jain And Sandeep Jain) (40.79%)
Highest Public shareholder
Ruby Qc Investment Holdings Pte Ltd (4.62%)
Individual Investors Holdings
3.33%
Board of Directors
Management
Designation
Remuneration
No Data
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Raw Materials Consumed
867.235
0%
Raw Materials Consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
1,010 Cr
(Quarterly Results - Dec 2024)
Net Profit:
65 Cr
Pharmaceuticals & Drugs
INR 6,910 Cr (Mid Cap)
308.00
33
0.00%
-0.09
0.78%
2.39
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
